Results 21 to 30 of about 30,181 (227)

Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. [PDF]

open access: yesPLoS ONE, 2013
Here we present mumps virus specific antibody levels in a large cross-sectional population-based serosurveillance study performed in the Netherlands in 2006/2007 (n = 7900).
Gaby Smits   +8 more
doaj   +1 more source

Establishing a small animal model for evaluating protective immunity against mumps virus. [PDF]

open access: yesPLoS ONE, 2017
Although mumps vaccines have been used for several decades, protective immune correlates have not been defined. Recently, mumps outbreaks have occurred in vaccinated populations.
Adrian Pickar   +6 more
doaj   +1 more source

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

open access: yesVaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk   +7 more
doaj   +1 more source

Easy and Rapid Detection of Mumps Virus by Live Fluorescent Visualization of Virus-Infected Cells. [PDF]

open access: yesPLoS ONE, 2015
Mumps viruses show diverse cytopathic effects (CPEs) of infected cells and viral plaque formation (no CPE or no plaque formation in some cases) depending on the viral strain, highlighting the difficulty in mumps laboratory studies. In our previous study,
Tadanobu Takahashi   +13 more
doaj   +1 more source

Sero-epidemiology of mumps in western Europe. [PDF]

open access: yes, 2003
Six countries (Denmark, England and Wales, France, Germany, Italy and The Netherlands) conducted large serological surveys for mumps, in the mid-1990s, as part of the European Sero-Epidemiology Network (ESEN).
Edmunds, WJ   +13 more
core   +1 more source

A new method for the detection of neutralizing antibodies against mumps virus. [PDF]

open access: yesPLoS ONE, 2013
Neutralization test is the most reliable method of evaluating immunity against viral diseases but there is no standard procedure for mumps virus, with tests differing in the infectivity of the challenge virus, 50% plaque reduction or complete inhibition ...
Keita Matsubara   +4 more
doaj   +1 more source

Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. [PDF]

open access: yes, 2007
The United Kingdom and United States have recently experienced large outbreaks of mumps, which raises concerns about vaccine effectiveness. The effectiveness of the mumps component of the measles, mumps, rubella (MMR) vaccine was estimated using the ...
Savage, Emma J   +15 more
core   +1 more source

No association between islet cell antibodies and coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7–19 years [PDF]

open access: yes, 1991
Viral antibodies were tested in a cohort of 44 isletcell antibody-positive individuals age 7–19 years, and 44 of their islet cell antibody-negative age and sex-matched classmates selected from a population study of 4208 pupils who had been screened for ...
Muir, Peter   +10 more
core   +1 more source

Molecular epidemiology of mumps viruses in the Netherlands, 2017-2019

open access: yesPLoS ONE, 2020
Mumps cases continue to occur, also in countries with a relatively high vaccination rate. The last major outbreaks of mumps in the Netherlands were in 2009–2012 and thereafter, only small clusters and single cases were reported.
Rogier Bodewes   +7 more
doaj   +2 more sources

Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain [PDF]

open access: yes, 2021
Background: Mumps is a vaccine-preventable disease but outbreaks have been reported in persons vaccinated with two doses of MMR vaccine. The objective was to describe the demographic features, vaccination effectiveness and genetic mumps virus diversity ...
Barrabeig i Fabregat, Irene   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy